195 related articles for article (PubMed ID: 32757703)
1. Ocular Manifestations of Sickle Cell Disease in Different Genotypes.
AlRyalat SA; Jaber BAM; Alzarea AA; Alzarea AA; Alosaimi WA; Al Saad M
Ophthalmic Epidemiol; 2021 Jun; 28(3):185-190. PubMed ID: 32757703
[TBL] [Abstract][Full Text] [Related]
2. Ocular Manifestations of Sickle Cell Disease: Signs, Symptoms and Complications.
AlRyalat SA; Nawaiseh M; Aladwan B; Roto A; Alessa Z; Al-Omar A
Ophthalmic Epidemiol; 2020 Aug; 27(4):259-264. PubMed ID: 32013659
[TBL] [Abstract][Full Text] [Related]
3. Ocular manifestations of sickle cell disease at the Korle-bu Hospital, Accra, Ghana.
Osafo-Kwaako A; Kimani K; Ilako D; Akafo S; Ekem I; Rodrigues O; Enweronu-Laryea C; Nentwich MM
Eur J Ophthalmol; 2011; 21(4):484-9. PubMed ID: 21058274
[TBL] [Abstract][Full Text] [Related]
4. Sickle Cell Disease in Jordan: The Experience of a Major Referral Center.
Oudat RI; Abualruz HS; Al-Shiek NKA; Al-Mashaqba EA; Al-Hiari RA; Alsoukhni HA; Hammad MAA
Med Arch; 2021 Feb; 75(1):27-30. PubMed ID: 34012195
[TBL] [Abstract][Full Text] [Related]
5. Use of an automated pyrosequencing technique for confirmation of sickle cell disease.
de Martino CC; Alencar CS; Loureiro P; Carneiro-Proietti ABF; Máximo CA; Mota RA; Rodrigues DOW; Gaburo Junior N; Kelly S; Sabino EC;
PLoS One; 2019; 14(12):e0216020. PubMed ID: 31830127
[TBL] [Abstract][Full Text] [Related]
6. Demographics and outcomes of hemoglobin genotype in hospitalized patients with COVID-19 and sickle cell disease in the United States.
Ilerhunmwuwa NP; Inyang L; Wasifuddin M; Aiwuyo H; Tahir M; Hakobyan N; Ankah P; Torere BE; Amaechi UM; Rayapureddy AK; Wang JC
Eur J Haematol; 2023 Oct; 111(4):611-619. PubMed ID: 37477175
[TBL] [Abstract][Full Text] [Related]
7. Adverse clinical and obstetric outcomes among pregnant women with different sickle cell disease genotypes.
Silva FAC; Ferreira ALCG; Hazin-Costa MF; Dias MLG; Araújo AS; Souza AI
Int J Gynaecol Obstet; 2018 Oct; 143(1):89-93. PubMed ID: 30030929
[TBL] [Abstract][Full Text] [Related]
8. A screening strategy for the detection of sickle cell retinopathy in pediatric patients.
Gill HS; Lam WC
Can J Ophthalmol; 2008 Apr; 43(2):188-91. PubMed ID: 18347621
[TBL] [Abstract][Full Text] [Related]
9. Monitoring retinal pathology and cerebral injury in sickle cell disease using spectral-domain optical coherence tomography in pediatric patients.
Jin J; Kandula V; Miller RE
Pediatr Blood Cancer; 2021 Jul; 68(7):e29028. PubMed ID: 33788385
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for venous thromboembolism in adults with hemoglobin SC or Sβ(+) thalassemia genotypes.
Yu TT; Nelson J; Streiff MB; Lanzkron S; Naik RP
Thromb Res; 2016 May; 141():35-8. PubMed ID: 26962984
[TBL] [Abstract][Full Text] [Related]
11. Sickle cell disease as a cause of osteonecrosis of the femoral head.
Milner PF; Kraus AP; Sebes JI; Sleeper LA; Dukes KA; Embury SH; Bellevue R; Koshy M; Moohr JW; Smith J
N Engl J Med; 1991 Nov; 325(21):1476-81. PubMed ID: 1944426
[TBL] [Abstract][Full Text] [Related]
12. [Sickle cell disease and retinal damage: a study of 38 cases at the African Tropical Ophthalmology Institute (IOTA) in Bamako].
Traoré J; Boitre JP; Bogoreh IA; Traoré L; Diallo A
Med Trop (Mars); 2006 Jun; 66(3):252-4. PubMed ID: 16924816
[TBL] [Abstract][Full Text] [Related]
13. HbS/β+ thalassemia: Really a mild disease? A National survey from the AIEOP Sickle Cell Disease Study Group with genotype-phenotype correlation.
Notarangelo LD; Agostini A; Casale M; Samperi P; Arcioni F; Gorello P; Perrotta S; Masera N; Barone A; Bertoni E; Bonetti E; Burnelli R; Casini T; Del Vecchio GC; Filippini B; Giona F; Giordano P; Gorio C; Marchina E; Nardi M; Petrone A; Colombatti R; Sainati L; Russo G
Eur J Haematol; 2020 Mar; 104(3):214-222. PubMed ID: 31788855
[TBL] [Abstract][Full Text] [Related]
14. Effect of α
Purohit P; Mohanty PK; Panigrahi J; Das K; Patel S
Hemoglobin; 2023 Jan; 47(1):11-18. PubMed ID: 37122241
[TBL] [Abstract][Full Text] [Related]
15. [Prevalence and risk factors for sickle retinopathy in a sub-Saharan comprehensive Sickle Cell Center].
Dembélé AK; Toure BA; Sarro YS; Guindo A; Fané B; Offredo L; Kené S; Conaré I; Tessougué O; Traoré Y; Badiaga Y; Sidibé MB; Diabaté D; Coulibaly M; Kanta M; Ranque B; Diallo DA
Rev Med Interne; 2017 Sep; 38(9):572-577. PubMed ID: 28237127
[TBL] [Abstract][Full Text] [Related]
16. Kidney Disease among Patients with Sickle Cell Disease, Hemoglobin SS and SC.
Drawz P; Ayyappan S; Nouraie M; Saraf S; Gordeuk V; Hostetter T; Gladwin MT; Little J
Clin J Am Soc Nephrol; 2016 Feb; 11(2):207-15. PubMed ID: 26672090
[TBL] [Abstract][Full Text] [Related]
17. Ocular findings in sickle cell disease patients in Lagos.
Akinsola FB; Kehinde MO
Niger Postgrad Med J; 2004 Sep; 11(3):203-6. PubMed ID: 15505651
[TBL] [Abstract][Full Text] [Related]
18. Retinal thickness measurements in sickle cell patients with HbSS and HbSC genotype.
Lim WS; Magan T; Mahroo OA; Hysi PG; Helou J; Mohamed MD
Can J Ophthalmol; 2018 Aug; 53(4):420-424. PubMed ID: 30119799
[TBL] [Abstract][Full Text] [Related]
19. Incidence of ocular abnormalities in patients with sickle hemoglobinopathies.
Friberg TR; Young CM; Milner PF
Ann Ophthalmol; 1986 Apr; 18(4):150-3. PubMed ID: 3592472
[TBL] [Abstract][Full Text] [Related]
20. [Sickle cell retinopathy in children: Report of 42 cases].
Saadouli D; Yahyaoui S; Ben Issa S; Ben Mansour K; Alaya N; Loukil I; Sammoud A; El Afrit MA
J Fr Ophtalmol; 2020 Apr; 43(4):319-323. PubMed ID: 32093957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
